标普和纳斯达克内在价值 联系我们

Dakshidin Corporation, Inc. DKSC OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
16/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Dakshidin Corporation, Inc. (DKSC) .

本页证实的标准:

  • VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分: 15/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score
16/100
SG Score
View full scorecard →
价值
N/A
No coverage
未來
N/A
No coverage
过去
0/100
→ Income
健康
0/100
Debt-to-Equity & liquidity
→ Health
~
护城河
50/100
→ Income
成长
15/100
→ Income
收入
N/A
No coverage

估值概览 — DKSC

估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.00
EV/EBITDA0.0
每股数据
EPS (TTM)$0.00
每股账面价值$0.00
每股营收$0.00
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%

EPS:实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2013 $0.00 $0.00 $-147.4K -
2016 $0.00 $0.00 $-2.2K -
2017 $0.00 $0.00 $-2.3K -
2018 $0.00 $0.00 $-13.63K -
2019 $0.00 $19.07K $-183.4K -961.9%
2020 $0.00 $208.25K $-7.88K -3.8%
2021 $0.00 $2.48K $-216.84K -8743.4%
2022 $0.00 $0.00 $-167.09K -
2023 $0.00 $0.00 $-17.72K -
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言